The effect of vitamin D on prevention of Diabetes

The comparative study of the effect of fortified yogurt with vitamin D, plain yogurt and vitamin D supplement on Glycemic, lipid and anthropometric indices in people with pre-diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016102615111N2

Enrollment

Registered

2017-02-24

Start date

2016-10-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prediabetes. Diabetes mellitus

Interventions

Intervention 1: Riched yogurt (100cc/day) with 1000 IU Vitamin D reciving group Intervention Duration: 3 month. Intervention 2: vitamin D supplement (1000 IU/day) receiving group. Intervention 3: pla

Prevention

Placebo

Riched yogurt (100cc/day) with 1000 IU Vitamin D reciving group Intervention Duration: 3 month

vitamin D supplement (1000 IU/day) receiving group

plain yoghurt (100cc/day) reciving group

Eligibility

Sex/Gender

All

Age

25 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria : Full consent of the individual, 25-65 years old, not family history of diabetes, lack of other chronic diseases (coronary heart, liver, kidney, thyroid, parathyroid, malabsorption, ...) or special circumstances such as pregnancy and breastfeeding, avoiding the use of any supplements or drugs and no smoking. Exclusion criteria :lack of interest in the continuation of cooperation, failure to follow the consumption of specified amount of fortified yogurt with vitamin D, plain yogurt and vitamin D supplement and require to use of oral anti diabetic drug.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
HbA1c. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pishtazteb HbA1c Kit.;2h-OGTT. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon OGTT Kit.;Vitamin D. Timepoint: Befor and 3 month after of intervention. Method of measurement: Vitamin D MONOBIND Kit.;Ca. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon Calcium Kit.;Serum insulin. Timepoint: Befor and 3 month after of intervention. Method of measurement: Insulin MONOBIND Kit.;FBS. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon glucose kit.;T-chol. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon Cholesterol Kit.;LDL-c. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon LDL- c Kit.;HDL-c. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon HDL- c Kit.;TG. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon Triglyceride Kit.;ALT. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon ALT Kit.;AST. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon AST Kit.	—

Measure

Time frame

HbA1c. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pishtazteb HbA1c Kit.;2h-OGTT. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon OGTT Kit.;Vitamin D. Timepoint: Befor and 3 month after of intervention. Method of measurement: Vitamin D MONOBIND Kit.;Ca. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon Calcium Kit.;Serum insulin. Timepoint: Befor and 3 month after of intervention. Method of measurement: Insulin MONOBIND Kit.;FBS. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon glucose kit.;T-chol. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon Cholesterol Kit.;LDL-c. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon LDL- c Kit.;HDL-c. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon HDL- c Kit.;TG. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon Triglyceride Kit.;ALT. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon ALT Kit.;AST. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon AST Kit.

—

Secondary

Measure	Time frame
HDL-c. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon HDL- c Kit.;2h-OGTT. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon OGTT Kit.;ALT. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon ALT Kit.;AST. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon AST Kit.;FBS. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon glucose kit.;Serum insulin. Timepoint: Befor and 3 month after of intervention. Method of measurement: Insulin MONOBIND Kit.;TG. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon Triglyceride Kit.;Vitamin D. Timepoint: Befor and 3 month after of intervention. Method of measurement: Vitamin D MONOBIND Kit.;Ca. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon Calcium Kit.;HbA1c. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pishtazteb HbA1c Kit.;T-chol. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon Cholesterol Kit.;LDL-c. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon LDL- c Kit.	—

Measure

Time frame

HDL-c. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon HDL- c Kit.;2h-OGTT. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon OGTT Kit.;ALT. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon ALT Kit.;AST. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon AST Kit.;FBS. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon glucose kit.;Serum insulin. Timepoint: Befor and 3 month after of intervention. Method of measurement: Insulin MONOBIND Kit.;TG. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon Triglyceride Kit.;Vitamin D. Timepoint: Befor and 3 month after of intervention. Method of measurement: Vitamin D MONOBIND Kit.;Ca. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon Calcium Kit.;HbA1c. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pishtazteb HbA1c Kit.;T-chol. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon Cholesterol Kit.;LDL-c. Timepoint: Befor and 3 month after of intervention. Method of measurement: Pars azmon LDL- c Kit.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRoghayeh Mostafai

Public Health faculty

r_mostafai@yahoo.com+98 83 3827 6394

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026